3u2d
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
[[Image:3u2d.png|left|200px]] | [[Image:3u2d.png|left|200px]] | ||
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_3u2d", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_3u2d| PDB=3u2d | SCENE= }} | {{STRUCTURE_3u2d| PDB=3u2d | SCENE= }} | ||
===S. aureus GyrB ATPase domain in complex with small molecule inhibitor=== | ===S. aureus GyrB ATPase domain in complex with small molecule inhibitor=== | ||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, {{ABSTRACT_PUBMED_22183167}}, adds the Publication Abstract to the page | ||
| - | (as it appears on PubMed at http://www.pubmed.gov), where 22183167 is the PubMed ID number. | ||
| - | --> | ||
{{ABSTRACT_PUBMED_22183167}} | {{ABSTRACT_PUBMED_22183167}} | ||
==About this Structure== | ==About this Structure== | ||
| - | [[3u2d]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Staphylococcus_aureus Staphylococcus aureus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3U2D OCA]. | + | [[3u2d]] is a 2 chain structure of [[Gyrase]] with sequence from [http://en.wikipedia.org/wiki/Staphylococcus_aureus Staphylococcus aureus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3U2D OCA]. |
| + | |||
| + | ==See Also== | ||
| + | *[[Gyrase|Gyrase]] | ||
==Reference== | ==Reference== | ||
Revision as of 21:57, 26 July 2012
Contents |
S. aureus GyrB ATPase domain in complex with small molecule inhibitor
Template:ABSTRACT PUBMED 22183167
About this Structure
3u2d is a 2 chain structure of Gyrase with sequence from Staphylococcus aureus. Full crystallographic information is available from OCA.
See Also
Reference
- Eakin AE, Green O, Hales N, Walkup GK, Bist S, Singh A, Mullen G, Bryant J, Embrey K, Gao N, Breeze A, Timms D, Andrews B, Uria-Nickelsen M, Demeritt J, Loch JT 3rd, Hull K, Blodgett A, Illingworth RN, Prince B, Boriack-Sjodin PA, Hauck S, Macpherson LJ, Ni H, Sherer B. Pyrrolamide DNA Gyrase Inhibitors: Fragment-based NMR Screening to Antibacterial Agents. Antimicrob Agents Chemother. 2011 Dec 19. PMID:22183167 doi:10.1128/AAC.05485-11
